Arnhold »

Terns Pharmaceuticals shares owned by Arnhold

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Arnhold from 13F filings

Historical chart of Arnhold investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Arnhold consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Arnhold

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6M 162k 52.72

More positions owned by Arnhold

Spdr Gold Tr Gold Shs (GLD)
Ishares Gold Tr Ishares New (IAU)
Lumentum Hldgs (LITE)
Coherent Corp (COHR)
Vertiv Holdings Com Cl A (VRT)
Alphabet Cap Stk Cl A (GOOGL)
At&t (T)
Broadcom (AVGO)
Raytheon Technologies Corp (RTX)
Pfizer (PFE)
SLM Corporation (SLM)
Cisco Systems (CSCO)
Xpo Logistics Inc equity (XPO)
Kyndryl Hldgs Common Stock (KD)
Bristol Myers Squibb (BMY)

View all positions for Arnhold

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals